About Roxane Laboratories
Roxane Laboratories is a Healthcare company based in Columbus (United States) founded in 1885, and was acquired by Hikma in July 2015. Manufacturer of generics products. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Roxane Laboratories was established in 1885 in Columbus, United States, within the generics pharmaceutical sector. Research, development, manufacturing, marketing, sales, and distribution of generic drugs are conducted, primarily targeting the United States market. Dosage forms such as immediate-release solids, nasal sprays, liquids, and sublingual tablets are produced. Key offerings include fluticasone, buprenorphine, methotrexate, prednisone, and calcium acetate, alongside branded pharmaceutical manufacturing.
- Headquarters Columbus, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website roxane.com
- Social LinkedIn
- Acquired by Hikma (Jul 2015)
Investors in Roxane Laboratories
Roxane Laboratories has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Hikma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Generics and pharmaceutical products are manufactured by Hikma. | 1978 | hikma.com | Amman, Jordan |
Investor details for Roxane Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Roxane Laboratories
2 dated milestones of Roxane Laboratories across 130 years, from founding to its latest funding, stage changes and deals.
- Founded Roxane Laboratories is founded.
- Exit Acquired by Hikma.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Roxane Laboratories (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Roxane Laboratories
Complete news archive for Roxane Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Roxane Laboratories
Roxane Laboratories was founded in 1885.
Roxane Laboratories is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Roxane Laboratories was established in 1885 in Columbus, United States, within the generics pharmaceutical sector. Research, development, manufacturing, marketing, sales, and distribution of generic drugs are conducted, primarily targeting the United States market. Dosage forms such as immediate-release solids, nasal sprays, liquids, and sublingual tablets are produced. Key offerings include fluticasone, buprenorphine, methotrexate, prednisone, and calcium acetate, alongside branded pharmaceutical manufacturing.
Roxane Laboratories has 1 investor. Key investors include Hikma.
Yes. Roxane Laboratories was acquired by Hikma in July 2015.